Ill SungNaMD

PubMed

• 48 citations
  Inhibition of Neovascularization to Simultaneously Ameliorate Graft-vs-Host Disease and Decrease Tumor Growth
  Olaf Penack, Erik Henke, David Suh, Christopher G. King, Odette M. Smith, Il-Kang Na, Amanda M. Holland, Arnab Ghosh, Sydney X. Lu, Robert R. Jenq, Chen Liu, George F....> ;Journal of the National Cancer Institute. 2010 Jun 16
• 13 citations
  Developmental stage–specific shift in responsiveness to chemokines during human B-cell development
  Marek Honczarenko, Aleksandra M. Glodek, Marcin Swierkowski, Il-Kang Na, Leslie E. Silberstein> ;Experimental Hematology. 2006 Aug 1
• Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation.
  Lu, S. X., Kappel, L. W., Charbonneau-Allard, A. M., Atallah, R., Holland, A. M., Turbide, C., Hubbard, V. M., Rotolo, J. A., Smith, M., Suh, D., King, C., Rao, U. K.,...> ;PLoS One. 2011
• Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL.
  Hanash, A. M., Kappel, L. W., Yim, N. L., Nejat, R. A., Goldberg, G. L., Smith, O. M., Rao, U. K., Dykstra, L., Na, I. K., Holland, A. M., Dudakov, J. A., Liu, C., Mur...> ;Blood. 2011 Jul 14
• Absence of P-selectin in recipients of allogeneic bone marrow transplantation ameliorates experimental graft-versus-host disease.
  Lu, S. X., Holland, A. M., Na, I. K., Terwey, T. H., Alpdogan, O., Bautista, J. L., Smith, O. M., Suh, D., King, C., Kochman, A., Hubbard, V. M., Rao, U. K., Yim, N., ...> ;J Immunol. 2010 Aug 1
• Concurrent visualization of trafficking, expansion, and activation of T lymphocytes and T-cell precursors in vivo.
  Na, I. K., Markley, J. C., Tsai, J. J., Yim, N. L., Beattie, B. J., Klose, A. D., Holland, A. M., Ghosh, A., Rao, U. K., Stephan, M. T., Serganova, I., Santos, E. B., ...> ;Blood. 2010 Sep 16
• Human peripheral blood and bone marrow Epstein-Barr virus-specific T-cell repertoire in latent infection reveals distinct memory T-cell subsets.
  Guerreiro, M., Na, I. K., Letsch, A., Haase, D., Bauer, S., Meisel, C., Roemhild, A., Reinke, P., Volk, H. D., Scheibenbogen, C.> ;Eur J Immunol. 2010 Jun
• The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease.
  Na, I. K., Lu, S. X., Yim, N. L., Goldberg, G. L., Tsai, J., Rao, U., Smith, O. M., King, C. G., Suh, D., Hirschhorn-Cymerman, D., Palomba, L., Penack, O., Holland, A....> ;J Clin Invest. 2010 Jan 01
• Human bone marrow as a source to generate CMV-specific CD4+ T cells with multifunctional capacity.
  Na, I. K., Letsch, A., Guerreiro, M., Bauer, S., Noack, I., Geginat, J., Reinke, P., Loesch, M., Kienapfel, H., Thiel, E., Volk, H. D., Scheibenbogen, C.> ;J Immunother. 2009 Nov 01
• NOD2 regulates hematopoietic cell function during graft-versus-host disease.
  Penack, O., Smith, O. M., Cunningham-Bussel, A., Liu, X., Rao, U., Yim, N., Na, I. K., Holland, A. M., Ghosh, A., Lu, S. X., Jenq, R. R., Liu, C., Murphy, G. F., Brand...> ;J Exp Med. 2009 Sep 28
• Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation.
  Jenq, R. R., King, C. G., Volk, C., Suh, D., Smith, O. M., Rao, U. K., Yim, N. L., Holland, A. M., Lu, S. X., Zakrzewski, J. L., Goldberg, G. L., Diab, A., Alpdogan, O...> ;Blood. 2009 Feb 12
• Nuclear expression of CXCR4 in tumor cells of non-small cell lung cancer is correlated with lymph node metastasis.
  Na, I. K., Scheibenbogen, C., Adam, C., Stroux, A., Ghadjar, P., Thiel, E., Keilholz, U., Coupland, S. E.> ;Hum Pathol. 2008 Dec
• Identification of truncated chemokine receptor 7 in human colorectal cancer unable to localize to the cell surface and unreactive to external ligands.
  Na, I. K., Busse, A., Scheibenbogen, C., Ghadjar, P., Coupland, S. E., Letsch, A., Loddenkemper, C., Stroux, A., Bauer, S., Thiel, E., Keilholz, U.> ;Int J Cancer. 2008 Oct 1
• Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits.
  Busse, A., Kraus, M., Na, I. K., Rietz, A., Scheibenbogen, C., Driessen, C., Blau, I. W., Thiel, E., Keilholz, U.> ;Cancer. 2008 Feb 1
• CMV-specific central memory T cells reside in bone marrow.
  Letsch, A., Knoedler, M., Na, I. K., Kern, F., Asemissen, A. M., Keilholz, U., Loesch, M., Thiel, E., Volk, H. D., Scheibenbogen, C.> ;Eur J Immunol. 2007 Nov
• Addition of GM-CSF to a peptide/KLH vaccine results in increased frequencies of CXCR3-expressing KLH-specific T cells.
  Na, I. K., Keilholz, U., Letsch, A., Bauer, S., Asemissen, A. M., Nagorsen, D., Thiel, E., Scheibenbogen, C.> ;Cancer Immunol Immunother. 2007 Mar
• Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer.
  Ghadjar, P., Coupland, S. E., Na, I. K., Noutsias, M., Letsch, A., Stroux, A., Bauer, S., Buhr, H. J., Thiel, E., Scheibenbogen, C., Keilholz, U.> ;J Clin Oncol. 2006 Apr 20
• Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2.
  Godal, R., Keilholz, U., Uharek, L., Letsch, A., Asemissen, A. M., Busse, A., Na, I. K., Thiel, E., Scheibenbogen, C.> ;Blood. 2006 Apr 15
• Expression of the chemokine receptors CXCR4, CXCR5, and CCR7 in primary central nervous system lymphoma.
  Jahnke, K., Coupland, S. E., Na, I. K., Loddenkemper, C., Keilholz, U., Korfel, A., Stein, H., Thiel, E., Scheibenbogen, C.> ;Blood. 2005 Jul 1
• Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor.
  Holdhoff, M., Kreuzer, K. A., Appelt, C., Scholz, R., Na, I. K., Hildebrandt, B., Riess, H., Jordan, A., Schmidt, C. A., Van Etten, R. A., Dörken, B., le Coutre, P.> ;Blood Cells Mol Dis. 2005 Feb 25
• Quantitative RT-PCR of Wilms tumor gene transcripts (WT1) for the molecular monitoring of patients with accelerated phase bcr/abl + CML.
  Na, I. K., Kreuzer, K. A., Lupberger, J., Dörken, B., le Coutre, P.> ;Leuk Res. 2005 Mar
• Imatinib in Philadelphia chromosome-positive chronic phase CML patients: molecular and cytogenetic response rates and prediction of clinical outcome.
  Le Coutre, P., Kreuzer, K. A., Na, I. K., Schwarz, M., Lupberger, J., Holdhoff, M., Baskaynak, G., Gschaidmeier, H., Platzbecker, U., Ehninger, G., Prejzner, W., Huhn,...> ;Am J Hematol. 2003 Aug
• Preexistence and evolution of imatinib mesylate-resistant clones in chronic myelogenous leukemia detected by a PNA-based PCR clamping technique.
  Kreuzer, K. A., Le Coutre, P., Landt, O., Na, I. K., Schwarz, M., Schultheis, K., Hochhaus, A., Dörken, B.> ;Ann Hematol. 2003 May
• Determination of alpha-1 acid glycoprotein in patients with Ph+ chronic myeloid leukemia during the first 13 weeks of therapy with STI571.
  le Coutre, P., Kreuzer, K. A., Na, I. K., Lupberger, J., Holdhoff, M., Appelt, C., Schwarz, M., Müller, C., Gambacorti-Passerini, C., Platzbecker, U., Bonnet, R., Ehni...> ;Blood Cells Mol Dis. 2002 Jan 01
• Fluorescent 5''-exonuclease assay for the absolute quantification of Wilms'' tumour gene (WT1) mRNA: implications for monitoring human leukaemias.
  Kreuzer, K. A., Saborowski, A., Lupberger, J., Appelt, C., Na, I. K., le Coutre, P., Schmidt, C. A.> ;Br J Haematol. 2001 Aug
• Join now to see all